Hearing:
Hybrid Hearing on “Examining Emergent BioSolutions’ Failure to Protect Public Health and Public Funds”
Select Subcommittee on the Coronavirus Crisis
Wednesday, May 19, 2021 (10:30 AM)
Select one
Washington, D.C.
Witnesses
Mr. Robert G. Kramer
President and Chief Executive Officer, Emergent BioSolutions, Inc.
Added
05/18/2021 at 01:38 PM
- Testimony
[PDF]
Added
05/19/2021 at 05:43 PM
Mr. Faud El-Hibri
Executive Chairman of the Board of Directors, Emergent BioSolutions, Inc.
Added
05/18/2021 at 01:38 PM
- Testimony
[PDF]
Added
05/19/2021 at 05:43 PM
Support Documents
- Notice
[PDF]
- Memo
[PDF]
Added
05/14/2021 at 05:49 PM
- Ranking Member Scalise UC - Article Regarding the President’s Plan on Intellectual Property in China
[PDF]
Added
06/17/2021 at 12:19 PM
Hearing Record
- Attendance
[PDF]
Added
05/20/2021 at 10:26 AM
- Questions for the Record Responses from Mr. Kramer
[PDF]
Added
06/17/2021 at 01:06 PM
- Questions for the Record Responses from Mr. El-Hibri
[PDF]
Added
06/17/2021 at 01:06 PM
- Transcript
[PDF]
Added
07/23/2021 at 05:23 PM
First Published:
May 11, 2021 at 05:41 PM
Last Updated:
July 23, 2021 at 05:23 PM